论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Liu X, Lou X, Cheng X, Meng Y
Received 12 October 2016
Accepted for publication 29 December 2016
Published 25 January 2017 Volume 2017:11 Pages 305—312
DOI https://doi.org/10.2147/DDDT.S124497
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Professor Jianbo Sun
Background: Metoprolol treatment is well established for chronic heart failure (CHF)
patients, but the central nervous system side effects are often a potential
drawback.
Objective: To investigate the impact of metoprolol treatment on
change in mental status of CHF patients with clinical psychological disorders
(such as depression, anxiety, and burnout syndrome).
Methods: From February 2013 to April 2016, CHF patients with
clinical mental disorders received metoprolol (23.75 or 47.5 mg, qd PO, dose
escalated with 23.75 mg each time until target heart rate [HR] <70 bpm was
achieved) at the Second Affiliated Hospital of Kunming Medical University.
Mental status was assessed by means of the Hospital Anxiety and Depression
Scale (HADS) and the Copenhagen Burnout Inventory (CBI) scale. The primary
outcome assessed was change in mental status of patients post-metoprolol
treatment and the association with reduction in HR achieved by metoprolol.
Results: A total of 154 patients (median age: 66.39 years;
males: n=101) were divided into eight groups on the basis of their mental
status. HR decreased significantly from baseline values in all the groups to
<70 bpm in the 12th month, P ≤0.0001. The HADS depression and
CBI scores significantly increased from baseline throughout the study frame (P ≤0.0001 for all groups), but a
significant decrease in the HADS anxiety score was observed in patients with
anxiety (P ≤0.0001 for all groups).
Regression analysis revealed no significant correlation in any of the groups between
the HR reduction and the change in the HADS/CBI scores, except for a change in
the CBI scores of CHF patients with depression (P =0.01),
which was HR dependent.
Conclusion: Metoprolol treatment worsens the depressive and high
burnout symptoms, but affords anxiolytic benefits independent of HR reduction
in CHF patients with clinical mental disorders. Hence, physicians need to be
vigilant while prescribing metoprolol in CHF patients who present with mental
disorders.
Keywords: metoprolol, chronic heart failure,
HADS anxiety and depression, high burnout, CBI scale, heart rate